We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > infliximab

News List

Celltrion's infliximab biosimilar to be tested for COVID-19 pharmatimes
June 17, 2020
Celltrion Healthcare has partnered with the University of Oxford and University Hospitals Birmingham to investigate the use of infliximab biosimilar CT-P13 as a treatment for COVID-19 symptoms.
Infliximab Introduction Has Not Cut IBD-Related Hospitalizations drugs
June 17, 2019
Infliximab Introduction Has Not Cut IBD-Related Hospitalizations.
Celltrion Healthcare & Pfizer’s biosimilar shows positive results in Crohn’s disease study europeanpharmaceuticalreview
May 08, 2019
Celltrion Healthcare presented the primary outcome from its pivotal randomised controlled trial of CT-P13 (biosimilar infliximab) in Crohn’s disease.
Biosimilar RENFLEXIS (infliximab) available on PBS from 1st August firstwordpharma
August 02, 2017
Potential for health budget savings with latest MSD biosimilar PBS listing;Infliximab biosimilar to be dispensed predominately through hospitals